Gestational diabetes--infant malformations and subsequent maternal glucose tolerance. 1986

J Farrell, and J M Forrest, and G N Storey, and D K Yue, and R P Shearman, and J R Turtle

The frequency of abnormal glucose tolerance in the first 12 months after gestational diabetes was found to be 33.3%, which is much higher than previously accepted. Women with gestational diabetes (Group 1 = 54 requiring insulin, Group 2 = 32 treated with diet alone) attending a metropolitan teaching hospital over a 3 1/2 year period were followed-up after delivery to determine their subsequent glucose tolerance. Of 86 seen 3 months after delivery, 2 had developed insulin-dependent diabetes mellitus (IDDM) and 2 noninsulin dependent diabetes mellitus (NIDDM), diagnosed by glucose tolerance testing. Another 38 returned for follow-up glucose tolerance testing at 12 months; of these 3 had impaired glucose tolerance (IGT), 7 had NIDDM, and one who had had NIDDM at 3 months now showed IGT after 9 months dietary treatment. Thus, 12 months after delivery, the cumulative prevalence of abnormal glucose tolerance was 14/42 (33.3%), 10 of the 42 being frankly diabetic (26%). Of the remaining 44 patients, 21 have not yet reached 12 months or were pregnant again, and 23 did not attend for glucose tolerance testing. Although the trend was for gestational diabetes mellitus (GDM) to recur earlier and more severely in subsequent pregnancies, in 3 instances the diabetes did not recur. Major congenital malformations occurred in 4 of the 86 babies (4.7%); minor malformations were found in a further 13 (15%) with no difference in frequency between Group 1 and Group 2.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011254 Pregnancy in Diabetics The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy. Pregnancy in Diabetes,Pregnancy in Diabete,Pregnancy in Diabetic
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Farrell, and J M Forrest, and G N Storey, and D K Yue, and R P Shearman, and J R Turtle
September 2023, Hypertension (Dallas, Tex. : 1979),
J Farrell, and J M Forrest, and G N Storey, and D K Yue, and R P Shearman, and J R Turtle
April 2003, Obstetrics and gynecology,
J Farrell, and J M Forrest, and G N Storey, and D K Yue, and R P Shearman, and J R Turtle
November 2002, Obstetrics and gynecology,
J Farrell, and J M Forrest, and G N Storey, and D K Yue, and R P Shearman, and J R Turtle
February 2014, The Cochrane database of systematic reviews,
J Farrell, and J M Forrest, and G N Storey, and D K Yue, and R P Shearman, and J R Turtle
July 2010, The Cochrane database of systematic reviews,
J Farrell, and J M Forrest, and G N Storey, and D K Yue, and R P Shearman, and J R Turtle
January 1997, The Medical journal of Australia,
J Farrell, and J M Forrest, and G N Storey, and D K Yue, and R P Shearman, and J R Turtle
November 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD,
J Farrell, and J M Forrest, and G N Storey, and D K Yue, and R P Shearman, and J R Turtle
January 1980, Diabetes care,
J Farrell, and J M Forrest, and G N Storey, and D K Yue, and R P Shearman, and J R Turtle
September 1997, Diabetes care,
J Farrell, and J M Forrest, and G N Storey, and D K Yue, and R P Shearman, and J R Turtle
October 1994, American journal of obstetrics and gynecology,
Copied contents to your clipboard!